换一批Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesothelioma.
第一单位：
Pulmonary Associates, Lehigh Valley Health Network, Allentown, PA, USA.
作者：
医学主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗代谢药, 抗肿瘤(Antimetabolites, Antineoplastic);女(雌)性(Female);随访研究(Follow-Up Studies);谷氨酸盐类(Glutamates);鸟嘌呤(Guanine);人类(Humans);免疫酶技术(Immunoenzyme Techniques);男(雄)性(Male);间皮瘤(Mesothelioma);中年人(Middle Aged);肿瘤分期(Neoplasm Staging);肽合酶类(Peptide Synthases);胸膜肿瘤(Pleural Neoplasms);预后(Prognosis);回顾性研究(Retrospective Studies);存活率(Survival Rate);胸苷酸合酶(Thymidylate Synthase);肿瘤细胞, 培养的(Tumor Cells, Cultured)
DOI
10.1097/JTO.0b013e318283da3e
PMID
23486267
发布时间
2022-04-14
基金项目
P01 CA066726/CA/NCI NIH HHS/United States
P30 ES013508/ES/NIEHS NIH HHS/United States
P30 CA016520/CA/NCI NIH HHS/United States
P30-ES013508/ES/NIEHS NIH HHS/United States
T32 HL007586/HL/NHLBI NIH HHS/United States
T32 HL07586/HL/NHLBI NIH HHS/United States
- 浏览25
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
